MedTrace Logo

Clinical Trials

NCT07198724 | RECRUITING | PHASE1/PHASE2
65 participants

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-10
Start Date:
2025-11-17
Completion:
2028-06-01
Conditions
  • Metastatic Breast Cancer
  • HER2 Low Breast Carcinoma
  • HER2-negative Breast Cancer
  • Breast Cancer
  • Breast Cancer Female
Interventions
  • DRUG
No Results Yet
NCT07192133 | RECRUITING | PHASE2
30 participants

Evaluation of CT-XPI

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-10
Start Date:
2026-01-26
Completion:
2026-12-31
Conditions
  • CT Scan
  • Computed Tomography
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT07158801 | RECRUITING | NA
110 participants

Project EMPOWER-OCD

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-10
Start Date:
2025-03-25
Completion:
2026-09-30
Conditions
  • Obsessive-Compulsive Disorder
Interventions
  • BEHAVIORAL
No Results Yet
NCT07132619 | COMPLETED
150 participants

AKI After Pulmonary Endarterectomy

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-10
Start Date:
2024-06-30
Completion:
2025-06-30
Conditions
  • Acute Kidney Injury
  • Acute Kidney Failure
  • Pulmonary Thromboembolisms
  • Hypothermic Circulatory Arrest Time
No Results Yet
NCT07125079 | RECRUITING
36 participants

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-10
Start Date:
2025-05-20
Completion:
2026-12-20
Conditions
  • ARDS (Acute Respiratory Distress Syndrome)
No Results Yet
NCT07094906 | NOT_YET_RECRUITING | NA
50 participants

Handgrip Exercise Training and CKD

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-10
Start Date:
2026-09-30
Completion:
2027-12-31
Conditions
  • Chronic Kidney Diseases
Interventions
  • DEVICE
No Results Yet
NCT07063979 | RECRUITING | NA
100 participants

Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-10
Start Date:
2025-11-04
Completion:
2027-07-31
Conditions
  • Postoperative Nausea and Vomiting
  • Bariatric Sleeve Gastrectomy
Interventions
  • DEVICE
No Results Yet
NCT07053436 | RECRUITING | PHASE2
300 participants

Horizon Two: HR NDMM (MMRC-100)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-10
Start Date:
2026-04-30
Completion:
2035-10-01
Conditions
  • High Risk Newly Diagnosed Multiple Myeloma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page